Medications & Supplements/Prescription Drugs

Levoxyl (levothyroxine) Tablets Recalled for Subpotency

Agency Publication Date: August 8, 2025

Summary

Pfizer is voluntarily recalling 29, 004 bottles of Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottles. The medication is subpotent, meaning it may not contain the full required amount of the active ingredient needed to treat thyroid conditions. If you are taking this medication, contact your healthcare provider or pharmacist for guidance.

Risk

Subpotent thyroid medication may not provide the necessary dose of hormone, potentially leading to symptoms of hypothyroidism or worsening of a patient's thyroid condition.

What You Should Do

The recalled product is Levoxyl (levothyroxine sodium tablets, USP), 50 mcg strength, sold in 100-count bottles under NDC 60793-851-01.
Identify if your bottle is affected by checking for lot number 24C11 with an expiration date of February 28, 2026 (Exp 2/28/2026) printed on the label.
If you have health concerns regarding your thyroid treatment, contact your healthcare provider or pharmacist immediately.
Return any unused product to the place of purchase for a refund, throw it away, or contact Pfizer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions or to report adverse effects.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Levoxyl (levothyroxine sodium tablets, USP) (100-count bottle)

Variants: 50 mcg

Lot Numbers:

24C11 (Exp 2/28/2026)

NDC:

60793-851-01

Distributed by Pfizer Inc., New York, NY.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97334

Status: Active

Manufacturer: Pfizer

Manufactured In: Austria

Units Affected: 29, 004 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

The recalled product is Levoxyl (levothyroxine sodium tablets, USP), 50 mcg strength, sold in 100-count bottles under NDC 60793-851-01.

Identify if your bottle is affected by checking for lot number 24C11 with an expiration date of February 28, 2026 (Exp 2/28/2026) printed on the label.

If you have health concerns regarding your thyroid treatment, contact your healthcare provider or pharmacist immediately.

Return any unused product to the place of purchase for a refund, throw it away, or contact Pfizer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions or to report adverse effects.